Stock STE STERIS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials STERIS plc

Equities

STE

IE00BFY8C754

Medical Equipment, Supplies & Distribution

Market Closed - Nyse
Other stock markets
 21:00:02 28/06/2024 BST 		5-day change 1st Jan Change
219.5 USD +1.43% Intraday chart for STERIS plc +0.65% -0.14%
06-07 Steris Insider Sold Shares Worth $839,960, According to a Recent SEC Filing MT
06-07 Steris Insider Sold Shares Worth $1,132,535, According to a Recent SEC Filing MT

Valuation

Fiscal Period: März 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 11,871 16,258 24,208 18,991 22,215 21,702 - -
Enterprise Value (EV) 1 11,871 16,258 24,208 18,991 22,215 24,165 23,630 23,997
P/E ratio 29.4 x 41.1 x 97.5 x 179 x 59 x 32.4 x 28.3 x 24.3 x
Yield 1.04% 0.82% 0.7% 0.96% - 1.02% 1.11% 1.21%
Capitalization / Revenue 3.92 x 5.23 x 5.28 x 3.83 x 4.04 x 3.92 x 3.72 x 3.53 x
EV / Revenue 3.92 x 5.23 x 5.28 x 3.83 x 4.04 x 4.37 x 4.05 x 3.9 x
EV / EBITDA 15.8 x 19.6 x 20.5 x 14.1 x - 15.5 x 14 x 15 x
EV / FCF 31.2 x 36.1 x 60.9 x - - 30.3 x 21.5 x 18.8 x
FCF Yield 3.2% 2.77% 1.64% - - 3.3% 4.66% 5.32%
Price to Book - 4.19 x - - - 3.12 x 2.93 x 2.74 x
Nbr of stocks (in thousands) 84,813 85,352 100,127 99,284 98,814 98,853 - -
Reference price 2 140.0 190.5 241.8 191.3 224.8 219.5 219.5 219.5
Announcement Date 13/05/20 18/05/21 11/05/22 10/05/23 08/05/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026 2027
Net sales 1 3,031 3,108 4,585 4,958 5,500 5,529 5,835 6,156
EBITDA 1 751.8 829.1 1,182 1,346 - 1,557 1,689 1,599
EBIT 1 628.6 699.4 1,077 1,170 - 1,304 1,405 1,390
Operating Margin 20.74% 22.51% 23.48% 23.6% - 23.59% 24.07% 22.58%
Earnings before Tax (EBT) 1 498.7 - 314.5 157.3 - 841.8 970.2 1,077
Net income 1 407.6 397.4 243.9 107 378.2 657.7 758.1 890.7
Net margin 13.45% 12.79% 5.32% 2.16% 6.88% 11.89% 12.99% 14.47%
EPS 2 4.760 4.630 2.480 1.070 3.810 6.780 7.747 9.050
Free Cash Flow 1 380.2 450.4 397.2 - - 797.1 1,101 1,276
FCF margin 12.54% 14.49% 8.66% - - 14.42% 18.87% 20.72%
FCF Conversion (EBITDA) 50.57% 54.32% 33.62% - - 51.2% 65.2% 79.75%
FCF Conversion (Net income) 93.28% 113.33% 162.88% - - 121.19% 145.24% 143.21%
Dividend per Share 2 1.450 1.570 1.690 1.840 - 2.232 2.428 2.660
Announcement Date 13/05/20 18/05/21 11/05/22 10/05/23 08/05/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1
Net sales 1 1,209 1,211 1,156 1,201 1,216 1,385 1,285 1,342 1,396 1,500 1,285 1,342 1,402 1,505 1,361
EBITDA 1 330.2 359.8 308.1 325.4 334.7 376.3 329.5 355.2 369.5 - 353.2 370.5 397.4 435.6 391.9
EBIT 1 289.9 286.1 264.8 285.3 290.7 329.2 287.4 302 322.7 - 288.5 304.7 331.6 366.8 317.6
Operating Margin 23.98% 23.63% 22.89% 23.77% 23.9% 23.77% 22.37% 22.5% 23.12% - 22.45% 22.7% 23.65% 24.37% 23.35%
Earnings before Tax (EBT) 1 - - 135 -333.1 160.3 195.1 157.9 150.2 179.3 - 168.6 196.9 226 251.4 213.1
Net income 1 143.6 52.26 111.3 -315.3 123.8 187.2 123.6 115.3 140.7 -1.4 134.5 151.7 173.6 197.8 167.9
Net margin 11.88% 4.32% 9.62% -26.26% 10.18% 13.52% 9.62% 8.59% 10.08% -0.09% 10.46% 11.3% 12.39% 13.14% 12.34%
EPS 2 1.420 0.5200 1.100 -3.150 1.240 1.880 1.250 1.160 1.420 -0.0100 1.395 1.557 1.775 2.043 1.677
Dividend per Share 2 0.4300 0.4300 0.4300 0.4700 0.4700 0.4700 0.4700 0.5200 0.5200 - 0.5200 0.5650 0.5650 0.5650 0.5650
Announcement Date 08/02/22 11/05/22 02/08/22 09/11/22 08/02/23 10/05/23 01/08/23 07/11/23 07/02/24 08/05/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 - - - - - 2,463 1,928 2,295
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) - - - - - 1.582 x 1.141 x 1.435 x
Free Cash Flow 1 380 450 397 - - 797 1,101 1,276
ROE (net income / shareholders' equity) 14.6% 14.6% 14.9% 13% - 12.4% 12.8% 11.9%
ROA (Net income/ Total Assets) 9.19% 8.82% 8.64% 7.39% - 7.55% 8.35% 6.4%
Assets 1 4,433 4,506 2,822 1,448 - 8,711 9,079 13,917
Book Value Per Share 2 - 45.50 - - - 70.30 75.00 80.10
Cash Flow per Share - - 6.960 - - - - -
Capex 1 215 239 288 362 - 360 387 412
Capex / Sales 7.08% 7.7% 6.27% 7.3% - 6.5% 6.63% 6.68%
Announcement Date 13/05/20 18/05/21 11/05/22 10/05/23 08/05/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for STERIS plc

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
219.5 USD
Average target price
241.9 USD
Spread / Average Target
+10.20%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
STERIS PLC Stock STERIS plc
-0.14% 21.7B
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.60% 181B
MEDTRONIC PLC Stock Medtronic plc
-4.45% 101B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.15% 67.54B
DEXCOM, INC. Stock DexCom, Inc.
-8.63% 45.09B
CENCORA, INC. Stock Cencora, Inc.
+9.70% 44.37B
HOYA CORPORATION Stock Hoya Corporation
+5.36% 40.7B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+15.22% 29.85B
TERUMO CORPORATION Stock Terumo Corporation
+10.26% 24.49B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-6.46% 23.99B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. STE Stock
  4. Financials STERIS plc